IceCure Medical To Exhibit at Society of Breast Imaging Symposium in National Harbor May 4-7
IceCure Medical is thrilled to be exhibiting at the upcoming 2023 Society of Breast Imaging (SBI) Symposium from May 4 – 7 at the Gaylord National Resort & Convention Center in National Harbor, Maryland. The conference offers a unique opportunity for breast imaging professionals to learn about breast cryoablation with our ProSense System. Visit us at […]
Meet IceCure at the 2023 American Society of Breast Surgeons (ASBrS) Annual Meeting in Boston
IceCure is thrilled to exhibit at this year’s American Society of Breast Surgeons 23nd Annual Meeting from April 26 – 30 in Boston, Massachusetts. Join us at Booth #816 and view live demos of the ProSense System for breast tumor cryoablation.
IceCure to Exhibit at European Conference on Interventional Oncology (ECIO) 2023 in Stockholm, Sweden
IceCure Medical is thrilled to participate as a Gold Sponsor in the 2023 European Conference on Interventional Oncology (ECIO) Meeting in Stockholm, Sweden from April 16 – 19. We have an exciting program of events, including several hands on sessions, scientific poster presentations, and a symposium moderated by Dr. Julien Frandon of CHU de Nîmes […]
IceCure Medical to Exhibit at National Consortium of Breast Centers Conference in Las Vegas, NV March 24 – 28
IceCure Medical is excited to be exhibiting at the National Consortium of Breast Centers 32nd Annual Interdisciplinary Breast Center Conference in Las Vegas, NV from March 24-28. Come visit us at booth #101! IceCure will be providing live demonstrations of our ProSense Cryoablation System at our booth.
Interventional oncology: a minimally invasive way to target cancer
The development of new and more effective cancer treatments is breaking previous limitations and providing clinicians with new and more capable tools to fight the disease. The traditional pillars of cancer treatment have been surgery, radiotherapy, and chemotherapy. Now cancer patients have the benefit of a fourth pillar, interventional oncology (IO), to diversify and personalize […]
IceCure to exhibit at the Society of Interventional Oncology (SIO) conference 2023 in Washington, DC
IceCure Medical is excited to be exhibiting at the 2023 Society of Interventional Oncology Annual Scientific Meeting in Washington, DC, January 19 – 23. IceCure representatives will be onsite to show you all the benefits our ProSense Cryoablation System has to offer and answer any of your questions about our liquid nitrogen based technology. Register today […]
When You Should Consider Lung Cryoablation for Treating Cancer
Cryoablation is a common minimally-invasive and effective procedure now adopted to treat a wide variety of benign and malignant tumors. In recent years, cryoablation is being adopted as the treatment of small lung tumors that are medically inoperable. How common is lung cancer in 2022? Lung cancer (both small cell and non-small cell) is the […]
Webinar: Cryoablation in the Thoracic Cavity
This webinar lead by Dr. Julien Frandon of the Department of Radiology at CHU de Nîmes discusses various cases performed with the ProSense™ Liquid Nitrogen (LN2) Based Cryoablation System in the thoracic cavity (i.e. lung, mediastinum). (60 minutes)
Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions
The aim of this retrospective study was to assess the feasibility of the IceCure’s single-probe liquid nitrogen system for tumor lesions of various sizes and locations, and to evaluate the safety of cryoablation with this technique.
Cryoablation Using Liquid Nitrogen for Metastatic Lung Cancers
This retrospective observational study conducted by Professor Hiroaki Nomori, MD found that cryoablation using liquid nitrogen would be one of the treatment methods for metastatic lung cancers <2.2 cm; and pulmonary function decreased significantly when cryoablation was performed for an increasing number of tumors.